Trial Profile

RESCUE: A Randomized, Blinded, Placebo-controlled, Parallel Group Design to Determine the Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular Thrombectomy

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 22 Apr 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs RNS 60 (Primary)
Indications Ischaemic stroke
Focus Adverse reactions; Proof of concept; Therapeutic Use
Acronyms RESCUE
Sponsors Revalesio

Most Recent Events

09 Apr 2025 According to a Revalesio media release, results from this study were presented in an oral presentation at the American Academy of Neurology 2025 Annual Meeting, held in San Diego, CA from April 5-9, 2025.
09 Apr 2025 Results presented in the Revalesio media release.
05 Feb 2025 Results published in the Revalesio media release

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com